Molluscum Contagiosum, Viral Warts, and Tinea Versicolor

  • Yuin-Chew Chan


Molluscum contagiosum and viral warts are common viral infections in children. They are benign infections that often resolve spontaneously in healthy children. Treatment is often sought to reduce cutaneous dissemination, social stigma and spread to close contacts. Painless topical therapy is often preferred for younger children. Older children may be able to tolerate more aggressive therapeutic modalities. A combination of treatment options is often used for recalcitrant viral warts and molluscum. Tinea (pityriasis) versicolor usually occurs in adolescents. It responds well to treatment with topical antifungal agents, but recurrence is common.


Human papilloma virus Molluscum contagiosum Pityriasis versicolor Malassezia 


  1. 1.
    Connell CO, Oranje A, Van Gysel D, Silverberg NB. Congenital molluscum contagiosum: report of four cases and review of the literature. Pediatr Dermatol. 2008;25:553–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Choong KY, Roberts LJ. Molluscum contagiosum, swimming and bathing: a clinical analysis. Australas J Dermatol. 1999;40:89–92.CrossRefPubMedGoogle Scholar
  3. 3.
    Braue A, Ross G, Varigos G, Kelly H. Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol. 2005;22:287–94.CrossRefPubMedGoogle Scholar
  4. 4.
    Hayashida S, Furusho N, Uchi H, Miyazaki S, Eiraku K, Gondo C, et al. Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis? J Dermatol Sci. 2010;60:173–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Treadwell PA. Eczema and infection. Pediatr Infect Dis J. 2008;27:551–2.CrossRefPubMedGoogle Scholar
  6. 6.
    Netchiporouk E, Cohen BA. Recognizing and managing eczematous id reactions to molluscum contagiosum virus in children. Pediatrics. 2012;129:e1072–5.CrossRefPubMedGoogle Scholar
  7. 7.
    van der Wouden JC, van der Sande R, van Suijlekom-Smit LW, Berger M, Butler CC, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2009;(4):CD004767.Google Scholar
  8. 8.
    Hanna D, Hatami A, Powell J, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol. 2006;23:574–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Moed L, Shwayder TA, Chang MW. Cantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol. 2001;137:1357–60.CrossRefPubMedGoogle Scholar
  10. 10.
    Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. 2000;43:503–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Coloe Dosal J, Stewart PW, Lin JA, Williams CS, Morrell DS. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial. Pediatr Dermatol. 2014;31(4):440–9 [Epub ahead of print].CrossRefPubMedGoogle Scholar
  12. 12.
    Mathes EF, Frieden IJ. Treatment of molluscum contagiosum with cantharidin: a practical approach. Pediatr Ann. 2010;39:124–8, 130.Google Scholar
  13. 13.
    Martín-García RF, García ME, Rosado A. Modified curettage technique for molluscum contagiosum. Pediatr Dermatol. 2007;24:192–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Simonart T, De Maertelaer V. Curettage treatment for molluscum contagiosum: a follow-up survey study. Br J Dermatol. 2008;159:1144–7.PubMedGoogle Scholar
  15. 15.
    Bard S, Shiman MI, Bellman B, Connelly EA. Treatment of facial molluscum contagiosum with trichloroacetic acid. Pediatr Dermatol. 2009;26:425–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Leslie KS, Dootson G, Sterling JC. Topical salicylic acid gel as a treatment for molluscum contagiosum in children. J Dermatolog Treat. 2005;16:336–40.CrossRefPubMedGoogle Scholar
  17. 17.
    Theos AU, Cummins R, Silverberg NB, Paller AS. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis. 2004;74(134–8):141–2.Google Scholar
  18. 18.
    Al-Mutairi N, Al-Doukhi A, Al-Farag S, Al-Haddad A. Comparative study on the efficacy, safety, and acceptability of imiquimod 5% cream versus cryotherapy for molluscum contagiosum in children. Pediatr Dermatol. 2010;27:388–94.CrossRefPubMedGoogle Scholar
  19. 19.
    Short KA, Fuller LC, Higgins EM. Double-blind, randomized, placebo-controlled trial of the use of topical 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Pediatr Dermatol. 2006;23:279–81.CrossRefPubMedGoogle Scholar
  20. 20.
    Handjani F, Behazin E, Sadati MS. Comparison of 10% potassium hydroxide solution versus cryotherapy in the treatment of molluscum contagiosum: an open randomized clinical trial. J Dermatolog Treat. 2014;25(3):249–50 [Epub ahead of print].CrossRefPubMedGoogle Scholar
  21. 21.
    Uçmak D, Akkurt MZ, Kacar SD, Sula B, Arica M. Comparative study of 5% and 2.5% potassium hydroxide solution for molluscum contagiosum in children. Cutan Ocul Toxicol. 2014;33(1):54–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70–9.CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Bruggink SC, de Koning MN, Gussekloo J, Egberts PF, Ter Schegget J, Feltkamp MC, Bavinck JN, Quint WG, Assendelft WJ, Eekhof JA. Cutaneous wart-associated HPV types: prevalence and relation with patient characteristics. J Clin Virol. 2012;55:250–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Silverberg NB. Human papillomavirus infections in children. Curr Opin Pediatr. 2004;16:402–9.CrossRefPubMedGoogle Scholar
  25. 25.
    van Haalen FM, Bruggink SC, Gussekloo J, Assendelft WJ, Eekhof JA. Warts in primary schoolchildren: prevalence and relation with environmental factors. Br J Dermatol. 2009;161:148–52.CrossRefPubMedGoogle Scholar
  26. 26.
    Kilkenny M, Merlin K, Young R, Marks R. The prevalence of common skin conditions in Australian school students: 1. Common, plane and plantar viral warts. Br J Dermatol. 1998;138:840–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Silverberg JI, Silverberg NB. The US prevalence of common warts in childhood: a population-based study. J Invest Dermatol. 2013;133:2788–90.CrossRefPubMedGoogle Scholar
  28. 28.
    Al-Mutairi N, AlKhalaf M. Mucocutaneous warts in children: clinical presentations, risk factors, and response to treatment. Acta Dermatovenerol Alp Panonica Adriat. 2012;21:69–72.Google Scholar
  29. 29.
    Bruggink SC, Eekhof JA, Egberts PF, van Blijswijk SC, Assendelft WJ, Gussekloo J. Natural course of cutaneous warts among primary schoolchildren: a prospective cohort study. Ann Fam Med. 2013;11:437–41.CrossRefPubMedCentralPubMedGoogle Scholar
  30. 30.
    Massing AM, Epstein WL. Natural history of warts. A two-year study. Arch Dermatol. 1963;87:306–10.CrossRefPubMedGoogle Scholar
  31. 31.
    Syrjänen S. Current concepts on human papillomavirus infections in children. APMIS. 2010;118:494–509.CrossRefPubMedGoogle Scholar
  32. 32.
    Rintala MA, Grénman SE, Järvenkylä ME, Syrjänen KJ, Syrjänen SM. High-risk types of human papillomavirus (HPV) DNA in oral and genital mucosa of infants during their first 3 years of life: experience from the Finnish HPV Family Study. Clin Infect Dis. 2005;41:1728–33.CrossRefPubMedGoogle Scholar
  33. 33.
    Sterling JC, Handfield-Jones S, Hudson PM, British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001;144:4–11.CrossRefPubMedGoogle Scholar
  34. 34.
    Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;9:CD001781.PubMedGoogle Scholar
  35. 35.
    Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol. 2002;19:263–6.CrossRefPubMedGoogle Scholar
  36. 36.
    Hengge UR, Esser S, Schultewolter T, Behrendt C, Meyer T, Stockfleth E, Goos M. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol. 2000;143:1026–31.CrossRefPubMedGoogle Scholar
  37. 37.
    Gelmetti C, Cerri D, Schiuma AA, Menni S. Treatment of extensive warts with etretinate: a clinical trial in 20 children. Pediatr Dermatol. 1987;4:254–8.CrossRefPubMedGoogle Scholar
  38. 38.
    Gladsjo JA, Alio Saenz AB, Bergman J, Krikorian G, Cunninghan BB. 5% 5-fluorouracil cream for treatment of verruca vulgaris in children. Pediatr Dermatol. 2009;26:279–85.CrossRefPubMedGoogle Scholar
  39. 39.
    Silverberg NB, Lim JK, Paller AS, Mancini AJ. Squaric acid immunotherapy for warts in children. J Am Acad Dermatol. 2000;42:803–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Micali G, Nasca MR, Tedeschi A, Dall’Oglio F, Pulvirenti N. Use of squaric acid dibutylester (SADBE) for cutaneous warts in children. Pediatr Dermatol. 2000;17:315–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Dasher DA, Burkhart CN, Morrell DS. Immunotherapy for childhood warts. Pediatr Ann. 2009;38:373–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol. 2002;146:423–31.CrossRefPubMedGoogle Scholar
  43. 43.
    Yaghoobi R, Sadighha A, Baktash D. Evaluation of oral zinc sulfate effect on recalcitrant multiple viral warts: a randomized placebo-controlled clinical trial. J Am Acad Dermatol. 2009;60:706–8.CrossRefPubMedGoogle Scholar
  44. 44.
    Coskey RJ. Treatment of plantar warts in children with a salicylic acid-podophyllin-cantharidin product. Pediatr Dermatol. 1984;2:71–3.CrossRefPubMedGoogle Scholar
  45. 45.
    Becerro de Bengoa Vallejo R, Losa Iglesias ME, Gómez-Martín B, Sánchez Gómez R, Sáez Crespo A. Application of cantharidin and podophyllotoxin for the treatment of plantar warts. J Am Podiatr Med Assoc. 2008;98:445–50.CrossRefPubMedGoogle Scholar
  46. 46.
    Youn SH, Kwon IH, Park EJ, Kim KH, Kim KJ. A two-week interval is better than a three-week interval for reducing the recurrence rate of hand-foot viral warts after cryotherapy: a retrospective review of 560 hand-foot viral warts patients. Ann Dermatol. 2011;23:53–60.CrossRefPubMedCentralPubMedGoogle Scholar
  47. 47.
    Berth-Jones J, Hutchinson PE. Modern treatment of warts: cure rates at 3 and 6 months. Br J Dermatol. 1992;127:262–5.CrossRefPubMedGoogle Scholar
  48. 48.
    Serour F, Somekh E. Successful treatment of recalcitrant warts in pediatric patients with carbon dioxide laser. Eur J Pediatr Surg. 2003;13:219–23.CrossRefPubMedGoogle Scholar
  49. 49.
    Sethuraman G, Richards KA, Hiremagalore RN, Wagner A. Effectiveness of pulsed dye laser in the treatment of recalcitrant warts in children. Dermatol Surg. 2010;36:58–65.CrossRefPubMedGoogle Scholar
  50. 50.
    Park HS, Kim JW, Jang SJ, Choi JC. Pulsed dye laser therapy for pediatric warts. Pediatr Dermatol. 2007;24:177–81.CrossRefPubMedGoogle Scholar
  51. 51.
    Crespo-Erchiga V, Florencio VD. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis. 2006;19:139–47.CrossRefPubMedGoogle Scholar
  52. 52.
    Sugita T, Suzuki M, Goto S, Nishikawa A, Hiruma M, Yamazaki T, Makimura K. Quantitative analysis of the cutaneous Malassezia microbiota in 770 healthy Japanese by age and gender using a real-time PCR assay. Med Mycol. 2010;48:229–33.CrossRefPubMedGoogle Scholar
  53. 53.
    Ramadán S, Sortino M, Bulacio L, Marozzi ML, López C, Ramos L. Prevalence of Malassezia species in patients with pityriasis versicolor in Rosario, Argentina. Rev Iberoam Micol. 2012;29:14–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Nanda A, Kaur S, Bhakoo ON, Kaur I, Vaishnavi C. Pityriasis (tinea) versicolor in infancy. Pediatr Dermatol. 1988;5:260–2.CrossRefPubMedGoogle Scholar
  55. 55.
    Chen GY, Cheng YW, Wang CY, Hsu TJ, Hsu MM, Yang PT, Chen WC. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: a community-based clinical survey. J Formos Med Assoc. 2008;107:21–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Jena DK, Sengupta S, Dwari BC, Ram MK. Pityriasis versicolor in the pediatric age group. Indian J Dermatol Venereol Leprol. 2005;71:259–61.CrossRefPubMedGoogle Scholar
  57. 57.
    Ogunbiyi AO, Owoaje E, Ndahi A. Prevalence of skin disorders in school children in Ibadan, Nigeria. Pediatr Dermatol. 2005;22:6–10.CrossRefPubMedGoogle Scholar
  58. 58.
    Ogunbiyi AO, Omigbodun Y, Owoaje E. Prevalence of skin disorders in school children in southwest Nigeria. Int J Adolesc Med Health. 2009;21:235–41.PubMedGoogle Scholar
  59. 59.
    Wu YH, Su HY, Hsieh YJ. Survey of infectious skin diseases and skin infestations among primary school students of Taitung County, eastern Taiwan. J Formos Med Assoc. 2000;99:128–34.PubMedGoogle Scholar
  60. 60.
    Terragni L, Lasagni A, Oriani A, Gelmetti C. Pityriasis versicolor in the pediatric age. Pediatr Dermatol. 1991;8:9–12.CrossRefPubMedGoogle Scholar
  61. 61.
    He SM, Du WD, Yang S, Zhou SM, Li W, Wang J, Xiao FL, Xu SX, Zhang XJ. The genetic epidemiology of tinea versicolor in China. Mycoses. 2008;51:55–62.PubMedGoogle Scholar
  62. 62.
    Terragni L, Lasagni A, Oriani A. Pityriasis versicolor of the face. Mycoses. 1991;34:345–7.CrossRefPubMedGoogle Scholar
  63. 63.
    Bouassida S, Boudaya S, Ghorbel R, Meziou TJ, Marrekchi S, Turki H, Zahaf A. [Pityriasis versicolor in children: a retrospective study of 164 cases]. Ann Dermatol Venereol. 1998;125:581–4.PubMedGoogle Scholar
  64. 64.
    Mayser P, Rieche I. Rapid reversal of hyperpigmentation in pityriasis versicolor upon short-term topical cycloserine application. Mycoses. 2009;52:541–3.CrossRefPubMedGoogle Scholar
  65. 65.
    Hu SW, Bigby M. Pityriasis versicolor: a systematic review of interventions. Arch Dermatol. 2010;146:1132–40.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Gleneagles Medical CentreSingaporeSingapore

Personalised recommendations